10 employees
Raze Therapeutics, Inc., a biotechnology company, engages in the discovery and development of oncology therapeutics.
2013
$24M
from 5 investors over 5 rounds
Raze Therapeutics, Inc. raised $24M on October 14, 2014
Investors: Astellas Venture Capital L.L.C., Atlas Venture, MPM Capital, M Ventures and Partners HealthCare